MeiraGTx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MeiraGTx and other ETFs, options, and stocks.About MGTX
MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs.
CEOAlexandria Forbes
CEOAlexandria Forbes
Employees381
Employees381
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees381
Employees381
MGTX Key Statistics
Market cap640.71M
Market cap640.71M
Price-Earnings ratio-3.77
Price-Earnings ratio-3.77
Dividend yield—
Dividend yield—
Average volume596.35K
Average volume596.35K
High today$8.36
High today$8.36
Low today$7.86
Low today$7.86
Open price$8.20
Open price$8.20
Volume514.12K
Volume514.12K
52 Week high$9.73
52 Week high$9.73
52 Week low$4.55
52 Week low$4.55
Stock Snapshot
As of today, MeiraGTx(MGTX) shares are valued at $7.96. The company's market cap stands at 640.71M, with a P/E ratio of -3.77.
As of 2025-12-19, MeiraGTx(MGTX) stock has fluctuated between $7.86 and $8.36. The current price stands at $7.96, placing the stock +1.3% above today's low and -4.8% off the high.
MeiraGTx(MGTX) shares are trading with a volume of 514.12K, against a daily average of 596.35K.
In the last year, MeiraGTx(MGTX) shares hit a 52-week high of $9.73 and a 52-week low of $4.55.
In the last year, MeiraGTx(MGTX) shares hit a 52-week high of $9.73 and a 52-week low of $4.55.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MGTX. This list is generated using Robinhood data, and it’s not a recommendation.